PHILLIPS, Gail Lewis,SAMPATH, Deepak,WERTZ, Ingrid
申请号：
DK16741212
公开号：
DK3319995T3
申请日:
2016.07.06
申请国别(地区):
DK
年份:
2019
代理人:
摘要：
The present invention is directed to a combination therapy involving an anti-HER2 antibody-drug conjugate and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a HER2-expressing cancer.
